Atlas Trials

Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients

Clinical trial NCT07114627 · RECRUITING

Trial details

NCT number
NCT07114627
Sponsor
Erasmus Medical Center
Status
RECRUITING
Study type
OBSERVATIONAL
Solid CancerGastric (Cardia, Body) CancerEsophageal CancerColorectal Cancer (CRC)
Start date
2025-02-18
Primary completion
2026-12-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.